Fifty percent prevalence of extracampine hallucinations in Parkinson's disease patients

Frontiers in Neurology

Volumn 6, Issue DEC, 2015, Pages

  Wood, Ruth A ^a   Hopkins, Sarah A ^b   Moodley, Kuven K ^a   Chan, Dennis ^c  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cortical Lewy body disease; Extracampine hallucinations; Hallucinations; Parkinson's disease; Visual hallucinations

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; BENZATROPINE; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; DONEPEZIL; ENTACAPONE; GALANTAMINE; PRAMIPEXOLE; RASAGILINE; RIVASTIGMINE; ROPINIROLE; ROTIGOTINE; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; AGED; ANOSMIA; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; EXTRACAMPINE HALLUCINATION; FEMALE; HALLUCINATION; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; ONLINE SYSTEM; PARKINSON DISEASE; PREDICTION; PREVALENCE; QUESTIONNAIRE; SLEEP DISORDER; SYMPTOM; VERY ELDERLY;

EID: 84954168846     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00263     Document Type: Article

References (37)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association (2013).
2. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology (1993) 43:2227-9. doi: 10.1212/WNL.43.11.2227.
3. Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord (2004) 19:1043-9. doi:10.1002/mds.20216.
4. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain (2000) 123(Pt 4):733-45. doi:10.1093/brain/123.4.733.
5. Chan D, Rossor MN. "-but who is that on the other side of you?" Extracampine hallucinations revisited. Lancet (2002) 360:2064-6. doi:10.1016/S0140-6736(02)11998-2.
6. Diederich NJ, Fenelon G, Stebbins G, Goetz CG. Hallucinations in Parkinson disease. Nat Rev Neurol (2009) 5:331-42. doi:10.1038/nrneurol.2009.62.
7. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol (2005) 4:605-10. doi:10.1016/S1474-4422(05)70146-0.
8. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 47:1113-24. doi:10.1212/WNL.47.5.1113.
9. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain (2002) 125:391-403. doi:10.1093/brain/awf033.
10. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol (1996) 53:1265-8. doi:10.1001/archneur.1996.00550120077019.
11. Gallagher DA, Parkkinen L, O'Sullivan SS, Spratt A, Shah A, Davey CC, et al. Testing an aetiological model of visual hallucinations in Parkinson's disease. Brain (2011) 134:3299-309. doi:10.1093/brain/awr225.
12. Ibarretxe-Bilbao N, Junque C, Marti MJ, Tolosa E. Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies. J Neurol Sci (2011) 310:79-81. doi:10.1016/j.jns.2011.06.019.
13. Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology (2004) 63:1409-16. doi:10.1212/01.WNL.0000141853.27081.BD.
14. Goetz CG, Tanner CM, Klawans HL. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry (1982) 139:494-7. doi:10.1176/ajp.139.4.494.
15. Cummings JL. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc (1991) 39:708-16. doi:10.1111/j.1532-5415.1991.tb03627.x.
16. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 342:1484-91. doi:10.1056/NEJM200005183422004.
17. Friedman JH. 'Drug holidays' in the treatment of Parkinson's disease. A brief review. Arch Intern Med (1985) 145:913-5. doi:10.1001/archinte.145.5.913.
18. Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol (1999) 56:595-601. doi:10.1001/archneur.56.5.595.
19. Pacchetti C, Manni R, Zangaglia R, Mancini F, Marchioni E, Tassorelli C, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord (2005) 20:1439-48. doi:10.1002/mds.20582.
20. Williams DR, Warren JD, Lees AJ. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry (2008) 79:652-5. doi:10.1136/jnnp.2007.124677.
21. Fenelon G, Alves G. Epidemiology of psychosis in Parkinson's disease. J Neurol Sci (2010) 289:12-7. doi:10.1016/j.jns.2009.08.014.
22. McDonald I. Musical alexia with recovery: a personal account. Brain (2006) 129:2554-61. doi:10.1093/brain/awl235.
23. Solomonova E, Nielsen T, Stenstrom P, Simard V, Frantova E, Donderi D. Sensed presence as a correlate of sleep paralysis distress, social anxiety and waking state social imagery. Conscious Cogn (2008) 17:49-63. doi:10.1016/j.concog.2007.04.007.
24. Zijlmans M, van Eijsden P, Ferrier CH, Kho KH, van Rijen PC, Leijten FS. Illusory shadow person causing paradoxical gaze deviations during temporal lobe seizures. J Neurol Neurosurg Psychiatry (2009) 80:686-8. doi:10.1136/jnnp.2008.154310.
25. Shackleton E. South. London: William Heinemann (1919).
26. Critchley M. Shipwreck Survivors: A Medical Study. London: JaAC Ltd (1943).
27. Brugger P, Regard M, Landis T, Oelz O. Hallucinatory experiences in extreme-altitude climbers. Neuropsychiatry Neuropsychol Behav Neurol (1999) 12:67-71.
28. Bertram K, Williams DR. Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry (2012) 83:448-52. doi:10.1136/jnnp-2011-300980.
29. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 22:1689-707; [quiz 1837]. doi:10.1002/mds.21507.
30. Kitayama M, Wada-Isoe K, Nakaso K, Irizawa Y, Nakashima K. Clinical evaluation of Parkinson's disease dementia: association with aging and visual hallucination. Acta Neurol Scand (2007) 116:190-5. doi:10.1111/j.1600-0404.2007.00860.x.
31. Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Tolosa E. Cognitive changes in Parkinson's disease patients with visual hallucinations. Dement Geriatr Cogn Disord (2007) 23:281-8. doi:10.1159/000100850.
32. Lee WJ, Tsai CF, Gauthier S, Wang SJ, Fuh JL. The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia. Int Psychogeriatr (2012) 24:1980-7. doi:10.1017/S1041610212001317.
33. Goetz CG. Scales to evaluate psychosis in Parkinson's disease. Parkinsonism Relat Disord (2009) 15(Suppl 3):S38-41. doi:10.1016/S1353-8020(09)70777-1.
34. Smith CA, Wicks PJ. PatientsLikeMe: consumer health vocabulary as a folksonomy. AMIA Annu Symp Proc (2008) 2008:682-6.
35. Sussex. Guidelines for Completing the Online Application Form for Ethical Review. Point 14 (2012) 10 p. Available from: https://www.sussex.ac.uk/webteam/gateway/file.php?name=guidance-for-completing-online application-form.pdf&site=377.
36. Field A. Discovering Statistics Using IBM SPSS Statistics. 4th ed. Thousand Oaks, CA: SAGE (2013).
37. Blanke O, Pozeg P, Hara M, Heydrich L, Serino A, Yamamoto A, et al. Neurological and robot-controlled induction of an apparition. Curr Biol (2014) 24:2681-6. doi:10.1016/j.cub.2014.09.049.